Daclizumab protects against cardiac transplant rejection

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1228, 2000-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Daclizumab: A Review of its Use in the Prevention of Acute Rejection in Renal Transplant Recipients

By Wiseman L.R. Faulds D.

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 1029-1042

Adis International

Access to resources Recommend Favorite

Daclizumab prevents rejection but increases the risk of death

Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Tacrolimus in transplant rejection

By Rath Thomas

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 115-122

Informa Healthcare

Access to resources Recommend Favorite

Daclizumab/sirolimus/tacrolimus: Eosinophilia in an Islet cell transplant recipient (first report with daclizumab): case report

Reactions Weekly, Vol. 1, Iss. 1056, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Hypoxia Inducible Factor-1 Protects Against Nitrate Tolerance and Stunning in Rabbit Cardiac Myocytes

By Tan Tao Weiss Harvey

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 2, 2010-04 ,pp. : 95-106

Springer Publishing Company

Access to resources Recommend Favorite